1- Brun G., Brun Jl. Tumeurs bénignes de l’utérus. In Gynécologie, coordonné par B.Hedon, P.Madelenat, D.Dargent, R.Frydman. Ellipses 111-119, 1998
2- Blanc B., Boubli L. Fibromes utérins. In Gynécologie ( 2ème Edition) Edition Pradel (Edisem) 380-395, 1993
3- Lansac J., Lecomte P. Fibromyomes utérins. In Gynécologie pour le praticien, 2ème edition ( SIMEP) 60-73, 1984
4- Marshburn PB, Matthews ML, Hurst BS. Uterine artery embolization as a treatment option for uterine myomas. Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44
5- Roman H, Loisel C, Puscasiu L, Sentilhes L, Marpeau L. Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37 Suppl 8:S405-17.
6- Tiltman A.J. The effect of progestins on the mitotic activity of uterine Fibromyomas Inter J. Gynecol Pathol 4: 89-96, 1985
7- Vavala V.,Lanzone A.,Monaco A., Scribanti A., Guida C.,Mancuso S. Postoperative GnRH analog treatment for the prevention of recurrences of uterine myomas after myomectomy. A pilot study. Gynecol Obstet Invest 43 : 251-4, 1997
8- Gunes M, Ozdegirmenci O, Kayikcioglu F, Haberal A, Kaplan M. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study. J Minim Invasive Gynecol. 2008 Nov-Dec;15(6):735-8.
9- Istre O. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):735-47.
10- Parker WH. Uterine myomas: management. Fertil Steril. 2007 Aug;88(2):255-71.
11- Practice Committee of American Society for Reproductive Medicine. Myomas and reproductive function. Fertil Steril. 2008 Nov;90(5 Suppl):S125-30
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025